Market Cap 530.17M
Revenue (ttm) 10.00M
Net Income (ttm) -29.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 28,075
Avg Vol 812,584
Day's Range N/A - N/A
Shares Out 140.26M
Stochastic %K 30%
Beta 0.88
Analysts Strong Sell
Price Target $6.80

Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian ca...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 33 3023 7300
Address:
One Cavendish Place, 4th Floor, London, United Kingdom
davedtire
davedtire Feb. 19 at 6:54 PM
$MREO both rare and mreo spiked same time
1 · Reply
Nhred1999
Nhred1999 Feb. 19 at 6:13 PM
$MREO So new 13 filings. Janus northpond and frazier closed their holdings 102 million but EcoR1 and 683 capitol took those shares 139 million.
1 · Reply
SebNo1234
SebNo1234 Feb. 19 at 5:13 PM
0 · Reply
Bgirl_smirk
Bgirl_smirk Feb. 19 at 7:47 AM
company reported approximately $41 million in cash and cash equivalents as of December 31, 2025, and updated its guidance to indicate this balance is expected to fund operations through mid-2027 lots of institutions and undervalued $MREO need catalyst but 2.50 I am looking for
1 · Reply
Mandi63
Mandi63 Feb. 19 at 7:47 AM
$AEON approval by FDA is a big deal.. two late stags indications fast track.,, $2.00-7.00 $AEON BULLISH FDA NOD OF APPROVAL $EOLS $OPEN $MREO
1 · Reply
SebNo1234
SebNo1234 Feb. 18 at 9:46 PM
$MREO AH...lets go!!
0 · Reply
PennyGod1759
PennyGod1759 Feb. 18 at 7:31 PM
$MREO 1+ incoming🙏
1 · Reply
poot_buttagina
poot_buttagina Feb. 18 at 7:25 PM
$MREO With Janus officially out of their 16mil shares there is now little selling pressure. A lot if them shares were picked up in dark pools by smaller institutions and helped to keep the price from cratering. All signs point to a massive V shape recovery with any positive news from the upcomibg conferences.
1 · Reply
SebNo1234
SebNo1234 Feb. 18 at 4:41 PM
0 · Reply
Crivit
Crivit Feb. 18 at 4:17 PM
$MREO $NVAX $VSTM 👊🤘
0 · Reply
Latest News on MREO
Mereo BioPharma Provides Update on Lead Clinical Programs

Jan 12, 2025, 11:05 AM EST - 1 year ago

Mereo BioPharma Provides Update on Lead Clinical Programs


davedtire
davedtire Feb. 19 at 6:54 PM
$MREO both rare and mreo spiked same time
1 · Reply
Nhred1999
Nhred1999 Feb. 19 at 6:13 PM
$MREO So new 13 filings. Janus northpond and frazier closed their holdings 102 million but EcoR1 and 683 capitol took those shares 139 million.
1 · Reply
SebNo1234
SebNo1234 Feb. 19 at 5:13 PM
0 · Reply
Bgirl_smirk
Bgirl_smirk Feb. 19 at 7:47 AM
company reported approximately $41 million in cash and cash equivalents as of December 31, 2025, and updated its guidance to indicate this balance is expected to fund operations through mid-2027 lots of institutions and undervalued $MREO need catalyst but 2.50 I am looking for
1 · Reply
Mandi63
Mandi63 Feb. 19 at 7:47 AM
$AEON approval by FDA is a big deal.. two late stags indications fast track.,, $2.00-7.00 $AEON BULLISH FDA NOD OF APPROVAL $EOLS $OPEN $MREO
1 · Reply
SebNo1234
SebNo1234 Feb. 18 at 9:46 PM
$MREO AH...lets go!!
0 · Reply
PennyGod1759
PennyGod1759 Feb. 18 at 7:31 PM
$MREO 1+ incoming🙏
1 · Reply
poot_buttagina
poot_buttagina Feb. 18 at 7:25 PM
$MREO With Janus officially out of their 16mil shares there is now little selling pressure. A lot if them shares were picked up in dark pools by smaller institutions and helped to keep the price from cratering. All signs point to a massive V shape recovery with any positive news from the upcomibg conferences.
1 · Reply
SebNo1234
SebNo1234 Feb. 18 at 4:41 PM
0 · Reply
Crivit
Crivit Feb. 18 at 4:17 PM
$MREO $NVAX $VSTM 👊🤘
0 · Reply
poot_buttagina
poot_buttagina Feb. 18 at 3:24 PM
$MREO So with bottom apparently being in at .35 and accumulation around. 40 yesterday this now looks primed to run up. Will keep up to date on H.C. Conf. updates over the next week or so for participation times as that can give insight into what may be presented. Any good news and a quick squeeze over a buck will occur.
1 · Reply
Bgirl_smirk
Bgirl_smirk Feb. 18 at 5:17 AM
$MREO I like it a lot
0 · Reply
peepthestamp
peepthestamp Feb. 17 at 10:42 PM
0 · Reply
Bgirl_smirk
Bgirl_smirk Feb. 17 at 7:35 PM
0 · Reply
lidopete
lidopete Feb. 17 at 7:03 PM
$MREO moving today, what's going on???
0 · Reply
SebNo1234
SebNo1234 Feb. 17 at 6:36 PM
0 · Reply
RTuckr
RTuckr Feb. 17 at 4:14 PM
$MREO OLE(?) wondering if any px tracked - if any are terminating, how fractures will be studied post ph3. Will check clinicaltrials later - if knowledgeable please share input. Rough numbers from what I remember: ORBIT 160. ~105 on Setru, ~55 placebo COSMIC ~60. Mereo & Rare looking at subgroup data now. Money + runway limited without approval and more ?s
0 · Reply
FloatRadar
FloatRadar Feb. 17 at 3:54 PM
$MREO Mereo BioPharma develops rare disease therapies, with clinical-stage pipeline and partnership-dependent future.
0 · Reply
poot_buttagina
poot_buttagina Feb. 17 at 12:37 AM
$MREO Sohere are the future catalyst here after this weeks non-compliance notice. Obviously news of 180 day extension gives it a good bump. Then there are three Healthcare conferences in early march. TD Cowen Mar. 2nd-4th, this is their first real chance to address non-compliance. Leerink Partners Mar. 9th-11th Our most likely day here is the 10th. This is more fireside chat where they will answer their failures on phase 3 and what their intentions are to get and keep the price above $1 without a split. Last is Barclays 24th annual HC Conf. Mar 10th-12th This is strictly management meeting one on one with investors...this is the conference to listen for Alvestat news. After this of course is earnings in the last week of March.
2 · Reply
Gunnar1
Gunnar1 Feb. 15 at 9:36 AM
$MREO This was published 2 months ago regarding alvelestat in Eur Respir J (doi: 10.1183/13993003.01019-2025.)
0 · Reply
Gunnar1
Gunnar1 Feb. 15 at 9:27 AM
$MREO New filing from Feb 13: Frazier Life Sciences no longer holds any MREO shares as of December 31, 2025. They have completely exited their position. https://mereobiopharma.gcs-web.com/static-files/afd0c3d6-6a91-4dee-a9bf-674ababf2ebd
0 · Reply
Gunnar1
Gunnar1 Feb. 15 at 9:15 AM
$MREO What I'm wondering is the state of the partnered programs regarding Leflutrozole and Navicixizumab, where MREO is eligible to get millions for several milestones. But I can't find any news regarding the progress Repro and Feng are making...
1 · Reply